-
The 8th European Association of Cardio-Thoracic Surgery (EACTS) Mechanical Circulatory Support (MCS) Summit was successfully held in Prague, Czech Republic from November 7 to 9, 2024. Dr. Chen Chen, founder of BrioHealth Technologies, along with Mr. Karl Nelson, Senior Clinical Operations Vice President, were invited to attend the summit.
-
The 18th European Mechanical Circulatory Support Summit (EUMS), a greatly influential international scientific conference in the field of advanced heart failure, was held in Hannover, Germany, from September 11 to 14, 2024 (local time). At the special session of “Best Outcomes: Post and Future of MCS” held on the third day, Prof. Gong Ming from Beijing Anzhen Hospital, Capital Medical University presented the multi-center study results of CH-VAD in his study report Clinical Outcomes in Patients With a Novel Fully Magnetically Levitated Left Ventricular Assist Device: A multi-center study on the international stage!
-
The 18th European Mechanical Circulatory Support Summit (EUMS) was successfully held from September 11th to 14th in Hannover, Germany. Dr. Chen Chen, founder of CH Biomedical, along with Mr. Karl Nelson, Sr. Clinical Operation VP, were invited to this prestigious event.
-
Recently, the landmark INNOVATE clinical trial of CH Biomedical’s BrioVAD has been approved for Medicare coverage by the U.S. Centers for Medicare & Medicaid Services (CMS). Under this approval, the required medical device, along with its associated routine examinations and services will be reimbursed by Medicare.
-
On May 11, 2024, the Fuwai Hospital single-center long-term outcomes of CH Biomedical’s CH-VAD, a fully magnetically levitated ventricular assist device were published online in The Journal of Heart and Lung Transplantation (JHLT), a leading international journal in cardiothoracic surgery, under the title “Long-term outcomes of a novel fully magnetically levitated ventricular assist device for the treatment of advanced heart failure in China” [1].
-
From May 29 to June 1, 2024, the 70th Annual Meeting of the American Society for Artificial Internal Organs (ASAIO) was held in Baltimore, Maryland, USA. CH Biomedical was the only VAD company form China invited to participate, where it showcased its latest R&D achievements and breakthrough innovations, drawing significant attention from the international VAD community.
